Company news

01 March 2018

GC Alkor Bio won a grant from the Fund for the Promotion of Innovation within the framework of the VI stage of the competition "Commercialization"

On February 22, the results of the sixth stage of the competitive selection under the program "Commercialization" were approved by the protocol of the Directorate of the Foundation for Assistance to Small Innovative Enterprises (Fund for the Promotion of Innovations). The group of companies Alkor Bio with the project "Production and commercialization of test systems for infectious and hormonal diagnostics by the method of immunochemical analysis" became the winner of the competition and now, according to its conditions, will receive a grant of 15 million rubles for the commercialization of R & D results.

25 December 2017

Merry Christmas and Happy New Year!

25 December 2017

Alkor Bio Group finished the year by launching new 14 allergens

At the last weeks of the 2017 year Alkor Bio Group has launched 14 new allergens. For the present time Alkor Bio catalogue includes 739 allergens, allergen mixes and allergen components.

All news
Science news
All articles

Group "Alcor Bio" was established in 2007 on the basis of "Alcor Bio, the national leader in the manufacture of diagnostic products based on enzyme immunoassay.

In 2002, the company Alkor Bio "was singled company" Trans-Technologies, which specializes in studying the biology of human stem cells. On the basis of experimental data specialists are developing new methods of treatment of various diseases using stem cells.

OOO "Diagnostic Centers Alkor Bio provides the population of St. Petersburg laboratory diagnostic services. Besides DC Alkor Bio "is a clinical testing ground for clinical validation of diagnostic products manufactured by Company Alkor Bio.